Cargando…
Developing evolution-resistant drugs for COVID-19
Analyzing how mutations affect the main protease of SARS-CoV-2 may help researchers develop drugs that are effective against current and future variants of the virus.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
eLife Sciences Publications, Ltd
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322998/ https://www.ncbi.nlm.nih.gov/pubmed/35880850 http://dx.doi.org/10.7554/eLife.81334 |